INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "SELTOREXANT FOR DELAYING RELAPSE, OR MAINTAINING STABLE RESPONSE OR REMISSION, IN A PATIENT HAVING MAJOR DEPRESSIVE DISORDER WITH INSOMNIA SYMPTOMS"

GENEVA, Feb. 9 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/EP2025/071854) for "SELTOREXANT FOR DELAYING RELAPSE, OR MAINTAINING STABLE RESPONSE OR REMISSION, IN A PATIENT HAVING MAJOR DEPRESSIVE DISORDER WITH INSOMNIA SYMPTOMS" on Jul 29, 2025. With publication no. WO/2026/027579, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DREVETS, Wayne (Janssen Research & Development, LLC920 US Route 202Raritan, New Jersey 08869), FLOSSBACH, Yanina (Actelion Pharmaceuticals LtdGewerbest...